Loading organizations...
Loading organizations...
Biotechnology company integrating AI in drug discovery and delivery.
METiS Therapeutics has raised $86.0M across 1 funding round.
METiS Therapeutics has raised $86.0M in total across 1 funding round.
METiS Therapeutics has raised $86.0M in total across 1 funding round.
METiS Therapeutics's investors include China Life, People's Insurance Company of China, 5Y Capital, Hongshan Capital Group (Sequoia Capital China), Lightspeed Venture Partners.
METiS Therapeutics has raised $86.0M across 1 funding round. Most recently, it raised $86.0M Series A in December 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 7, 2021 | $86.0M Series A | China Life, People's Insurance Company of China | 5Y Capital, Hongshan Capital Group (Sequoia Capital China), Lightspeed Venture Partners |